The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
More than two years following the last in-person RESI event, Life Science Nation is pleased to announce that RESI returns to an in-person format September 21-22 at the Westin Copley Place in Boston, MA. September 23 is a day dedicated to digital partnering for virtual and in-person attendees to take advantage of. Since the virtual shift, RESI has navigated the digital world and grown but remains dedicated to its mission: to connect early-stage startups in life science and healthcare with investors and licensing partners who are a fit for their product and stage of development.
The team behind RESI has learned much about what the community looks for in reliable, high-quality partnering, and looks forward to providing invaluable content with convenient and dynamic partnering options, which include both in-person (September 21-22) and virtual (September 23) options. In-person attendees can expect two days of active partnering, interactive panels, educational workshops, and live pitch sessions. Virtual attendees can still benefit from access to content recordings, as well as a single day dedicated exclusively to digital partnering.